Terms: = Prostate cancer AND TOP1, RP3-511B24_2, 7150, ENSG00000198900, TOPI, P11387 AND Diagnosis
8311 results:
1. A Community-Based prostate cancer Screening and Education Program for Asian American Men in Medically Underserved Communities.
Cho D; Gor B; Hwang H; Wang X; Hernandez M; Jones LA; Frost J; Roberson P; Pettaway CA
Int J Environ Res Public Health; 2024 Mar; 21(4):. PubMed ID: 38673327
[TBL] [Abstract] [Full Text] [Related]
2. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
Lee LJ; Han CJ; Saligan L; Wallen GR
Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
[TBL] [Abstract] [Full Text] [Related]
3. Developing a Novel Enzalutamide-Resistant prostate cancer Model via AR F877L Mutation in LNCaP Cells.
Wang R; Ma S; Xu N; Gan Y; Li P; Zhang J; Zhang Z; Gu Q; Xiang J
Curr Protoc; 2024 Apr; 4(4):e1033. PubMed ID: 38652202
[TBL] [Abstract] [Full Text] [Related]
4. [Construction of a model based on multipoint full-layer puncture biopsy for predicting pathological complete response after neoadjuvant therapy for locally advanced rectal cancer].
Jin Y; Zhai ZW; Sun LT; Xia PD; Hu H; Jiang CQ; Zhao BC; Qu H; Qian Q; Dai Y; Yao HW; Wang ZJ; Han JG
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):403-411. PubMed ID: 38644246
[No Abstract] [Full Text] [Related]
5. Racial and Ethnic Variation in Receipt and Intensity of Active Surveillance for Older Patients With Localized prostate cancer.
Basourakos SP; An A; Davuluri M; Pinheiro LC; Al Awamlh BAH; Borregales LD; Luan D; Tamimi RM; Hu JC; Kensler KH
Urol Pract; 2024 May; 11(3):538-546. PubMed ID: 38640417
[TBL] [Abstract] [Full Text] [Related]
6. [Application of 1470 nm semiconductor laser in the treatment of benign prostatic hyperplasia in ultra-aged patients].
Wu D; Yi XM; Wei HX; Zhang KX; Shi CJ; Shi XQ; Xu ZY; Fu D
Zhonghua Nan Ke Xue; 2023 Sep; 29(9):831-836. PubMed ID: 38639597
[TBL] [Abstract] [Full Text] [Related]
7. [Clinical study of artificial intelligence-guided image fusion assisted transperineal prostate biopsy].
Hu J; Zhao XD; Zhou YL; Dong N; Ma MF; Chen YH; Sheng ZC; Dong J; He CQ; Xu S
Zhonghua Nan Ke Xue; 2023 Aug; 29(8):729-735. PubMed ID: 38619521
[TBL] [Abstract] [Full Text] [Related]
8. Do beta-blockers reduce negative intrusive thoughts and anxiety in cancer survivors? - An emulated trial.
Ehrencrona C; Li Y; Angenete E; Haglind E; Franzén S; Grimby-Ekman A; Bock D
BMC Cancer; 2024 Apr; 24(1):447. PubMed ID: 38605350
[TBL] [Abstract] [Full Text] [Related]
9. [A single center study：An analysis of the safety and validity of delaying repeated biopsy for patients with atypical small acinar proliferation].
Ji WT; Liu DC; Cui WL; Hu Y; Wang Y; Tan JF
Zhonghua Nan Ke Xue; 2023 May; 29(5):414-419. PubMed ID: 38602757
[TBL] [Abstract] [Full Text] [Related]
10. Excess weight, weight gain, and prostate cancer risk and prognosis: the PROCA-life study.
Støyten M; Knutsen T; Stikbakke E; Agledahl I; Wilsgaard T; Eggen AE; Richardsen E; Giovannucci E; Thune I; Haugnes HS
Acta Oncol; 2024 Apr; 63():154-163. PubMed ID: 38591351
[TBL] [Abstract] [Full Text] [Related]
11. Combination of prostate volume and apparent diffusion coefficient can stratify patients with a PI-RADS score of 3 to reduce unnecessary prostate biopsies.
Dong Q; Wang C; Shen D; Ma Y; Zhang B; Xu S; Tao T; Xiao J
Prostate; 2024 Jun; 84(8):780-787. PubMed ID: 38558415
[TBL] [Abstract] [Full Text] [Related]
12. The treatment landscape of nonmetastatic castrate resistant prostate cancer: A contemporary perspective.
Yanada BA; Homewood D; Dias BH; Ogluszko C; Corcoran NM
Urol Oncol; 2024 Jun; 42(6):175.e9-175.e18. PubMed ID: 38555235
[TBL] [Abstract] [Full Text] [Related]
13. Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis.
Hemminki K; Zitricky F; Sundquist K; Sundquist J; Försti A; Hemminki A; Hemminki O
Cancer Med; 2024 Apr; 13(7):e7126. PubMed ID: 38545829
[TBL] [Abstract] [Full Text] [Related]
14. CD44 and CD133 protein expression might serve as a prognostic factor for early occurrence castration-resistant prostate cancer.
Dwina Y; Zaid LSM; Saraswati M; Rachmadi L; Kekalih A; Rahadiani N; Louisa M; Agustina H; Mochtar CA; Hamid ARAH
Prostate; 2024 Jun; 84(8):738-746. PubMed ID: 38528654
[TBL] [Abstract] [Full Text] [Related]
15. DNA methylation markers for risk of metastasis in a cohort of men with localized prostate cancer.
Habeshian TS; Cannavale KL; Slezak JM; Shu YH; Chien GW; Chen X; Shi F; Siegmund KD; Van Den Eeden SK; Huang J; Chao CR
Epigenetics; 2024 Dec; 19(1):2308920. PubMed ID: 38525786
[TBL] [Abstract] [Full Text] [Related]
16. DiagSet: a dataset for prostate cancer histopathological image classification.
Koziarski M; Cyganek B; Niedziela P; Olborski B; Antosz Z; Żydak M; Kwolek B; Wąsowicz P; Bukała A; Swadźba J; Sitkowski P
Sci Rep; 2024 Mar; 14(1):6780. PubMed ID: 38514661
[TBL] [Abstract] [Full Text] [Related]
17. Adrenal-Permissive Germline HSD3B1 Allele and prostate cancer Outcomes.
McKay RR; Nelson TJ; Pagadala MS; Teerlink CC; Gao A; Bryant AK; Agiri FY; Guram K; Thompson RF; Pridgen KM; Seibert TM; Lee KM; Carter H; Lynch JA; Hauger RL; Rose BS
JAMA Netw Open; 2024 Mar; 7(3):e242976. PubMed ID: 38506808
[TBL] [Abstract] [Full Text] [Related]
18. Benefit and risk of oral anticoagulant initiation strategies in patients with atrial fibrillation and cancer: a target trial emulation using the SEER-Medicare database.
Truong B; Hornsby L; Fox B; Chou C; Zheng J; Qian J
J Thromb Thrombolysis; 2024 Apr; 57(4):638-649. PubMed ID: 38504063
[TBL] [Abstract] [Full Text] [Related]
19. Synchronous versus metachronous spinal metastasis: a comparative study of survival outcomes following neurosurgical treatment.
Banat M; Potthoff AL; Hamed M; Borger V; Scorzin JE; Lampmann T; Asoglu H; Khalafov L; Schmeel FC; Paech D; Radbruch A; Nitsch L; Weller J; Herrlinger U; Toma M; Gielen GH; Vatter H; Schneider M
J Cancer Res Clin Oncol; 2024 Mar; 150(3):136. PubMed ID: 38502313
[TBL] [Abstract] [Full Text] [Related]
20. Compliance With NCCN Guidelines for Evaluation and Treatment of Anemia Among Patients With Solid Tumors.
Hufnagel DH; Bos LM; Brown AJ; Prescott LS
J Natl Compr Canc Netw; 2024 Mar; 22(3):. PubMed ID: 38489926
[TBL] [Abstract] [Full Text] [Related]
[Next]
